Evidence map›Paper›PMID 35852697›Full record

ArticleInternational journal of hematology2022

Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia.

Takeshi Hagino, Tomohiko Sato, Reina Saga, Hiroko Hidai, Yoshiro Murai, Hideki Akiyama, Sayuri Motomura

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takeshi HaginoDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan. hagip.homa@gmail.com.ORCID http://orcid.org/0000-0002-3164-9641
Tomohiko SatoDivision of Transfusion Medicine and Cell Therapy, The Jikei University Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8244-075X
Reina SagaDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan.
Hiroko HidaiDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan.
Yoshiro MuraiDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan.
Hideki AkiyamaDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan.
Sayuri MotomuraDepartment of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment, Corporation 1-7-1 Aobachou, Higashimurayama-shi, Tokyo, 189-8511, Japan.
Tokyo Metropolitan Tama-Hokubu Medical Center · JPThe Jikei University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of myeloid leukocytosis in leukemia patients during antileukemic treatment requires a differential diagnosis between myeloid leukemoid reaction and leukemia progression. We herein report the case of an 80-year-old Japanese man with chronic myelomonocytic leukemia (CMML) who developed marked myeloid leukocytosis (36.3 × 10

Indexed as

Leukemia, Myelomonocytic, ChronicLeukemia, Myelomonocytic, JuvenileLeukemoid ReactionAged, 80 and overAzacitidineHumansLeukocytosisMaleAzacitidineAzacitidineChronic myelomonocytic leukemiaGranulocyte colony-stimulating factor (G-CSF)Myeloid leukemoid reaction

Identifiers

PMID35852697
OpenAlexW4285796513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.